Endogenous and Exogenous Factors and Somatic Characteristics of Early Onset Colorectal Cancers

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Pathology".

Deadline for manuscript submissions: closed (28 February 2021) | Viewed by 15391

Special Issue Editor


E-Mail Website
Guest Editor
Gastroenterology and Gastrointestinal Endoscopy Unit, Vita-Salute San Raffaele University, San Raffaele Scientific Institute, Milan, Italy
Interests: gastrointestinal hereditary tumors; Lynch syndrome; familial adenomatous polyposis; Peutz Jeghers syndrome; hereditary pancreatic cancer; familial pancreatic cancer; familial diffuse gastric cancer; serrated polyposis

Special Issue Information

Dear Colleagues,

Firstly described in U.S., an increase of left-sided early-onset Colorectal Cancers (eoCRCs) has been confirmed globally. Several endogenous and exogenous associated factors have been described in eoCRC pathogenesis, including family history of CRC, obesity, alcohol habits, physical activity, and western diet. CRCs in young patients present a significant challenge in terms of treatment and prevention. Emerging data suggest tumors from young individuals have distinguishing clinical, pathological, biological, and molecular features, suggesting that eoCRC is a fundamentally different subtype of CRC. It is likely that future oncological treatment algorithms will need to adopt a more personalized approach tailored to the individual patient’s tumor. Most of the differences between early and late onset colorectal cancers seem to involve subtle differences in the genetic and epigenetic background. Meticulous investigations into the molecular events implicated in eoCRC will help to develop novel approaches for targeted precision therapies.

Prof. Dr. Giulia Martina Cavestro
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • early onset colorectal cancer
  • associated risk factors
  • diagnosis
  • miRNA signature

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

10 pages, 788 KiB  
Article
Clinical, Pathological and Molecular Characteristics of Chilean Patients with Early-, Intermediate- and Late-Onset Colorectal Cancer
by Karin Alvarez, Alessandra Cassana, Marjorie De La Fuente, Tamara Canales, Mario Abedrapo and Francisco López-Köstner
Cells 2021, 10(3), 631; https://doi.org/10.3390/cells10030631 - 12 Mar 2021
Cited by 6 | Viewed by 2626
Abstract
Colorectal cancer (CRC) is the second most frequent neoplasm in Chile and its mortality rate is rising in all ages. However, studies characterizing CRC according to the age of onset are still lacking. This study aimed to identify clinical, pathological, and molecular features [...] Read more.
Colorectal cancer (CRC) is the second most frequent neoplasm in Chile and its mortality rate is rising in all ages. However, studies characterizing CRC according to the age of onset are still lacking. This study aimed to identify clinical, pathological, and molecular features of CRC in Chilean patients according to the age of diagnosis: early- (≤50 years; EOCRC), intermediate- (51–69 years; IOCRC), and late-onset (≥70 years; LOCRC). The study included 426 CRC patients from Clinica Las Condes, between 2007 and 2019. A chi-square test was applied to explore associations between age of onset and clinicopathological characteristics. Body Mass Index (BMI) differences according to age of diagnosis was evaluated through t-test. Overall (OS) and cancer-specific survival (CSS) were estimated by the Kaplan–Meier method. We found significant differences between the age of onset, and gender, BMI, family history of cancer, TNM Classification of Malignant Tumors stage, OS, and CSS. EOCRC category was characterized by a family history of cancer, left-sided tumors with a more advanced stage of the disease but better survival at 10 years, and lower microsatellite instability (MSI), with predominant germline mutations. IOCRC has shown clinical similarities with the EOCRC and molecular similarities to the LOCRC, which agrees with other reports. Full article
Show Figures

Figure 1

Review

Jump to: Research

15 pages, 1407 KiB  
Review
Disparities in Early-Onset Colorectal Cancer
by Charles Muller, Ehizokha Ihionkhan, Elena M. Stoffel and Sonia S. Kupfer
Cells 2021, 10(5), 1018; https://doi.org/10.3390/cells10051018 - 26 Apr 2021
Cited by 27 | Viewed by 6606
Abstract
The incidence and mortality of early-onset colorectal cancer (CRC) are increasing in the United States (US) and worldwide. In the US, there are notable disparities in early-onset CRC burden by race/ethnicity and geography. African Americans, Hispanic/Latinos, and populations residing in specific regions of [...] Read more.
The incidence and mortality of early-onset colorectal cancer (CRC) are increasing in the United States (US) and worldwide. In the US, there are notable disparities in early-onset CRC burden by race/ethnicity and geography. African Americans, Hispanic/Latinos, and populations residing in specific regions of the Southern U.S. are disproportionately affected with CRC diagnosed at younger ages, while less is known about disparities in other countries. Reasons for these disparities are likely multi-factorial and potentially implicate differences in health determinants including biology/genetics, diet/environment, individual health behaviors, and access to high-quality health services, as well as social and policy factors. This review summarizes current understanding of early-onset CRC disparities and identifies specific research areas that will inform evidence-based interventions at individual, practice, and policy levels to reduce the global burden of this disease. Full article
Show Figures

Figure 1

19 pages, 788 KiB  
Review
The Inherited and Familial Component of Early-Onset Colorectal Cancer
by Maria Daca Alvarez, Isabel Quintana, Mariona Terradas, Pilar Mur, Francesc Balaguer and Laura Valle
Cells 2021, 10(3), 710; https://doi.org/10.3390/cells10030710 - 23 Mar 2021
Cited by 39 | Viewed by 5450
Abstract
Early-onset colorectal cancer (EOCRC), defined as that diagnosed before the age of 50, accounts for 10–12% of all new colorectal cancer (CRC) diagnoses. Epidemiological data indicate that EOCRC incidence is increasing, despite the observed heterogeneity among countries. Although the cause for such increase [...] Read more.
Early-onset colorectal cancer (EOCRC), defined as that diagnosed before the age of 50, accounts for 10–12% of all new colorectal cancer (CRC) diagnoses. Epidemiological data indicate that EOCRC incidence is increasing, despite the observed heterogeneity among countries. Although the cause for such increase remains obscure, ≈13% (range: 9–26%) of EOCRC patients carry pathogenic germline variants in known cancer predisposition genes, including 2.5% of patients with germline pathogenic variants in hereditary cancer genes traditionally not associated with CRC predisposition. Approximately 28% of EOCRC patients have family history of the disease. This article recapitulates current evidence on the inherited syndromes that predispose to EOCRC and its familial component. The evidence gathered support that all patients diagnosed with an EOCRC should be referred to a specialized genetic counseling service and offered somatic and germline pancancer multigene panel testing. The identification of a germline pathogenic variant in a known hereditary cancer gene has relevant implications for the clinical management of the patient and his/her relatives, and it may guide surgical and therapeutic decisions. The relative high prevalence of hereditary cancer syndromes and familial component among EOCRC patients supports further research that helps understand the genetic background, either monogenic or polygenic, behind this increasingly common disease. Full article
Show Figures

Graphical abstract

Back to TopTop